Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 10, 2015 - Issue
Submit an article Journal homepage
90
Views
28
CrossRef citations to date
0
Altmetric
Original Research

Zabofloxacin versus moxifloxacin in patients with COPD exacerbation: a multicenter, double-blind, double-dummy, randomized, controlled, Phase III, non-inferiority trial

Chin Kook Rhee1 Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Seoul St Mary’s Hospital, College of Medicine, The Catholic University of Korea, Korea
,
Jung Hyun Chang2 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, School of Medicine, Ewha Womans University Medical Center, Seoul, Korea
,
Eu gene Choi3 Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Daejeon Hankook Hospital, Daejeon, Korea
,
Hyun kuk Kim4 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea
,
Yong-Soo Kwon5 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chonnam National University Hospital, Gwangju, Korea
,
Sun Young Kyung6 Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea
,
Ji-Hyun Lee7 Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, CHA Bundang Medical Center of CHA University, Seongnam, Korea
,
Myung Jae Park8 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, KyungHee University Hospital, Seoul, Korea
,
Kwang Ha Yoo9 Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea
&
Yeon Mok Oh10 Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KoreaCorrespondence[email protected]
 show all
Pages 2265-2275 | Published online: 22 Oct 2015

References

  • PelaRMarchesaniFAgostinelliCAirways microbial flora in COPD patients in stable clinical conditions and during exacerbations: a bronchoscopic investigationMonaldi Arch Chest Dis19985332622679785808
  • SethiSMurphyTFInfection in the pathogenesis and course of chronic obstructive pulmonary diseaseN Engl J Med2008359222355236519038881
  • WedzichaJASinghRMackayAJAcute COPD exacerbationsClin Chest Med201435115716324507843
  • ParkHSKimHJSeolMJChoiDRChoiECKwakJHIn vitro and in vivo antibacterial activities of DW-224a, a new fluoronaphthyridoneAntimicrob Agents Chemother20065062261226416723601
  • KwonARMinYHRyuJMChoiDRShimMJChoiECIn vitro and in vivo activities of DW-224a, a novel fluoroquinolone antibiotic agentJ Antimicrob Chemother200658368468816873394
  • Kosowska-ShickKCreditoKPankuchGAAntipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agentsAntimicrob Agents Chemother20065062064207116723567
  • PetitpretzPChoneCTremolieresFLevofloxacin 500 mg once daily versus cefuroxime 250 mg twice daily in patients with acute exacerbations of chronic obstructive bronchitis: clinical efficacy and exacerbation-free intervalInt J Antimicrob Agents2007301525917512704
  • Urueta-RobledoJArizaHJardimJRMoxifloxacin versus levofloxacin against acute exacerbations of chronic bronchitis: the Latin American CohortRespir Med200610091504151116504492
  • ChodoshSDeAbateCAHaverstockDAneiroLChurchDShort-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study GroupRespir Med2000941182710714475
  • WilsonRKubinRBallinIFive day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitisJ Antimicrob Chemother199944450151310588312
  • DeAbateCAMathewCPWarnerJHHeydAChurchDThe safety and efficacy of short course (5-day) moxifloxacin vs azithromycin in the treatment of patients with acute exacerbation of chronic bronchitisRespir Med200094111029103711127487
  • ZervosMMartinezFJAmsdenGWRothermelCDTreadwayGEfficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitisInt J Antimicrob Agents2007291566117189096
  • GrassiCCasaliLCurtiETellariniMLazzaroCSchitoGEfficacy and safety of short course (5-day) moxifloxacin vs 7-day ceftriaxone in the treatment of acute exacerbations of chronic bronchitis (AECB)J Chemother200214659760812583552
  • StarakisIGogosCABassarisHFive-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitisInt J Antimicrob Agents200423212913715013037
  • LiuKXXuBWangJEfficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis and COPD: a systematic review and meta-analysisJ Thorac Dis20146322122924624286
  • KimHJSeolMJParkHSAntimicrobial activity of DW-224a, a new fluoroquinolone, against Streptococcus pneumoniaeJ Antimicrob Chemother20065761256125816603643
  • ParkHSJungSJKwakJHChoiDRChoiECDNA gyrase and topoisomerase IV are dual targets of zabofloxacin in Streptococcus pneumoniaeInt J Antimicrob Agents2010361979820403681
  • WilliamsLShackclothJJungYHMorrisseyIActivity of DW-224a and comparators against atypical bacterial respiratory pathogensPaper presented at: Interscience Conference on Antimicrobial Agents and ChemotherapyOctober 30; 2004Washington, DC
  • KimYSKimMJBackKRA phase 2, multi-dose, double-blind, randomized, multicenter, safety and efficacy study of zabofloxacin vs moxifloxacin in the treatment of mild to moderate community-acquired pneumoniaPaper presented at: Interscience Conference on Antimicrobial Agents and ChemotherapySeptember 9; 2012San Francisco, CA

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.